PARAGON 28 INC (FNA)
US69913P1057 - Common Stock
FNA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. The financial health of FNA is average, but there are quite some concerns on its profitability. FNA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FNA has reported negative net income.
FNA had a negative operating cash flow in the past year.
In multiple years FNA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: FNA reported negative operating cash flow in multiple years.
1.2 Ratios
FNA has a Return On Assets (-14.04%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -26.92%, FNA is in line with its industry, outperforming 59.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.04% | ||
| ROE | -26.92% | ||
| ROIC | N/A |
ROA(3y)-15.46%
ROA(5y)-7.89%
ROE(3y)-27.27%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
FNA has a Gross Margin of 79.85%. This is amongst the best in the industry. FNA outperforms 91.19% of its industry peers.
In the last couple of years the Gross Margin of FNA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for FNA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.85% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.05%
GM growth 5YN/A
2. Health
2.1 Basic Checks
FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FNA has more shares outstanding
The debt/assets ratio for FNA is higher compared to a year ago.
2.2 Solvency
FNA has an Altman-Z score of 2.74. This is not the best score and indicates that FNA is in the grey zone with still only limited risk for bankruptcy at the moment.
FNA's Altman-Z score of 2.74 is fine compared to the rest of the industry. FNA outperforms 67.36% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that FNA is somewhat dependend on debt financing.
FNA's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. FNA is outperformed by 69.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.74 |
ROIC/WACCN/A
WACC9.53%
2.3 Liquidity
FNA has a Current Ratio of 4.21. This indicates that FNA is financially healthy and has no problem in meeting its short term obligations.
FNA has a better Current ratio (4.21) than 62.69% of its industry peers.
A Quick Ratio of 2.30 indicates that FNA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.30, FNA is in line with its industry, outperforming 47.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The earnings per share for FNA have decreased by -7.55% in the last year.
The Revenue has grown by 19.30% in the past year. This is quite good.
Measured over the past years, FNA shows a very strong growth in Revenue. The Revenue has been growing by 24.92% on average per year.
EPS 1Y (TTM)-7.55%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-53.33%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y24.92%
Revenue growth 5YN/A
Revenue growth Q2Q17.57%
3.2 Future
FNA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
FNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.51% yearly.
EPS Next Y62.53%
EPS Next 2Y21.99%
EPS Next 3Y19.61%
EPS Next 5Y13.72%
Revenue Next Year20.09%
Revenue Next 2Y17.78%
Revenue Next 3Y18.36%
Revenue Next 5Y18.51%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
FNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
FNA's earnings are expected to grow with 19.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.99%
EPS Next 3Y19.61%
5. Dividend
5.1 Amount
No dividends for FNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PARAGON 28 INC
NYSE:FNA (5/13/2024, 7:26:43 PM)
After market: 8.11 0 (0%)8.11
+0.36 (+4.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap672.40M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.04% | ||
| ROE | -26.92% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.85% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.21 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-7.55%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y62.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.3%
Revenue growth 3Y24.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y